RGD Reference Report - [Mechanism of chondrocyte apoptosis in Kashin-Beck disease and primary osteoarthritis: a comparative study]. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

[Mechanism of chondrocyte apoptosis in Kashin-Beck disease and primary osteoarthritis: a comparative study].

Authors: Wang, SJ  Guo, X  Chen, JH  Ren, FL  Guo, R  Liu, JJ  Zhang, ZT 
Citation: Wang SJ, etal., Nan Fang Yi Ke Da Xue Xue Bao. 2006 Jul;26(7):927-30.
RGD ID: 10054095
Pubmed: PMID:16864079   (View Abstract at PubMed)

OBJECTIVE: To investigate chondrocyte apoptosis and the expressions of Bcl-2, Bax, Fas and iNOS in the articular cartilage between Kashin-Beck disease (KBD) and primary osteoarthritis (OA) and explore the difference in pathogenesis between the two diseases. METHODS: The articular cartilage specimens were collected from 15 normal human subjects, 15 adult patients with KBD and 15 with OA. Chondrocyte apoptosis was detected by TUNEL method, and the expressions of Bcl-2, Bax, Fas and iNOS in articular cartilage were examined with B-SA immunohistochemistry. RESULTS: The percentages of apoptotic chondrocytes positive for TUNEL staining in the articular cartilage were significantly higher in patients with KBD and OA than in normal control subjects (F=20.90-53.16, df=42, P<0.01), and the erosive areas of the articular cartilage contained greater percentage of apoptotic chondrocytes than the non-erosive areas in the same patient with KBD (t=4.154, df=28, P<0.01) or OA (t=6.004, df=28, P<0.01). No significant difference was noted in the positive apoptotic chondrocytes between KBD and OA (t=1.329-1.362, df=28, P>0.05). The percentage of chondrocytes positive for Bcl-2, Bax, Fas and iNOS were significantly higher in KBD and OA patients than in the control subjects (F=25.46-215.31, df=42, P<0.01), and significant differences were observed in Bcl-2, Bax, Fas and iNOS expressions between the erosed areas and non-erosed areas in articular cartilage in patients with KBD (t=2.608-7.77, df=28, P<0.05) and OA (t=2.278-5.413, df=28, P<0.05), but their expressions showed no significant difference between the two diseases (t=0.284-1.590, df=28, P>0.05). CONCLUSION: There was no significant difference in apoptotic chondrocytes and Bcl-2, Bax, Fas and iNOS expressions in the cartilage between adult patients with KBD and OA.



RGD Manual Disease Annotations    Click to see Annotation Detail View

  
Object SymbolSpeciesTermQualifierEvidenceWithNotesSourceOriginal Reference(s)
BAXHumanosteoarthritis  IEP protein:increased expression:chondrocyteRGD 
BCL2Humanosteoarthritis  IEP protein:increased expression:chondrocyteRGD 
BaxRatosteoarthritis  ISOBAX (Homo sapiens)protein:increased expression:chondrocyteRGD 
BaxMouseosteoarthritis  ISOBAX (Homo sapiens)protein:increased expression:chondrocyteRGD 
Bcl2Ratosteoarthritis  ISOBCL2 (Homo sapiens)protein:increased expression:chondrocyteRGD 
Bcl2Mouseosteoarthritis  ISOBCL2 (Homo sapiens)protein:increased expression:chondrocyteRGD 

Objects Annotated

Genes (Rattus norvegicus)
Bax  (BCL2 associated X, apoptosis regulator)
Bcl2  (BCL2, apoptosis regulator)

Genes (Mus musculus)
Bax  (BCL2-associated X protein)
Bcl2  (B cell leukemia/lymphoma 2)

Genes (Homo sapiens)
BAX  (BCL2 associated X, apoptosis regulator)
BCL2  (BCL2 apoptosis regulator)


Additional Information